marijuana stocks news

Form 8-K for LEXARIA CORP.


20-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Lexaria test results on nitric oxide filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.Exhibit No. Description

99.1 News Release dated January 20, 2016


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$MCIG Announces Special Investors Conference Call to Discuss 2017 Outlook

mCig, Inc. Announces Special Investors Conference Call to Discuss 2017 Outlook (…

AbbVie Inc. (ABBV) Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic Outcomes

Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic…

$INSY to Present at Jefferies 2015 Healthcare Conference

Insys Therapeutics to Present at Jefferies 2015 Healthcare Conference Insys Therapeutics, Inc.…

$DIGPD Opens Flagship Cannabis Testing Laboratory and Signs Initial Client

DigiPath Opens Flagship Cannabis Testing Laboratory and Signs Initial Client  As a…